{"id":"W4410822217","doi":"10.1200/jco.2025.43.16_suppl.tps3174","title":"A phase 1/2 dose escalation study of the oral DNA polymerase theta inhibitor (POLQi) GSK4524101 ± niraparib in adults with advanced or metastatic solid tumors.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Cancer research; Internal medicine; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001478391,0.001864778,0.0017742,0.0004470484,0.0003861181,0.0008600656,0.0009011274,0.001159522,0.004665364],"category_scores_gemma":[0.0007088613,0.0006888742,0.001021491,0.0004022791,0.000675295,0.0009399393,0.000375374,0.003464816,0.001218918],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009709427,"about_ca_system_score_gemma":0.001811836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001021656,"about_ca_topic_score_gemma":0.002567604,"domain_scores_codex":[0.9996165,0.0001592099,0.00002032615,0.00007786296,0.00004418654,0.00008185057],"domain_scores_gemma":[0.9994696,0.00006393298,0.00009667946,0.0000417874,0.00003556269,0.0002925716],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5664921,0.1996286,0.00767648,0.001135352,0.001037852,0.0004583949,0.0004845239,0.002681056,0.05585489,0.0004381638,0.008294244,0.1558183],"study_design_scores_gemma":[0.5123261,0.4709565,0.008355461,0.00003087902,0.0002659623,0.0003403205,0.00006299999,0.0007848181,0.00276813,0.0001996549,0.003885332,0.00002373914],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840343,0.002298291,0.0009966734,0.0007152524,0.0001818626,0.007167595,0.001777787,0.0001731833,0.002655123],"genre_scores_gemma":[0.9717011,0.003216205,0.004683916,0.002071589,0.0002691899,0.008428781,0.003809014,0.00006540529,0.005754755],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004665364,"threshold_uncertainty_score":0.01560724,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09521809611650829,"score_gpt":0.5079753282935783,"score_spread":0.41275723217707,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}